Gene · 51316
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome wide functional analysis of HBx expressing human hepatocytes stimulated with endothelial cell cross-talk. | Genomics | 2023 | 37209778 | PubTator, text mining | PubMed |
| Placenta-specific 8 facilitates the infection of duck hepatitis A virus type 1 by inhibiting the TLR7 MyD88-dependent signaling pathway. | Poult Sci | 2023 | 37207573 | PubTator, text mining | PubMed |
| Parent-reported health-related quality of life in pediatric childhood cancer survivors and factors associated with poor health-related quality of life in aftercare. | Qual Life Res | 2023 | 37204653 | PubTator, text mining | PubMed |
| A dual functional polypeptide with antibacterial and anti-inflammatory properties for the treatment of periodontitis. | Int J Biol Macromol | 2023 | 37196724 | PubTator, text mining | PubMed |
| FGF-trapping hampers cancer stem-like cells in uveal melanoma. | Cancer Cell Int | 2023 | 37165394 | PubTator, text mining | PubMed |
| Molecular Characterization of katG and inhA Mutations by Genotype MTBDRplus Line Probe Assay To Guide Isoniazid and Ethionamide Use for Drug-Resistant Tuberculosis. | Cureus | 2023 | 37153291 | PubTator, text mining | PubMed |
| Building consensus around the assessment and interpretation of Symbiodiniaceae diversity. | PeerJ | 2023 | 37151292 | PubTator, text mining | PubMed |
| Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. | Cell Stem Cell | 2023 | 37146584 | PubTator, text mining | PubMed |
Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics. | Front Immunol | 2023 | 37138889 | PubTator, text mining | PubMed |
| New Insight into the Reactivity of S,S-Bis-ylide. | Molecules | 2023 | 37110528 | PubTator, text mining | PubMed |
| Transcriptomics unravels molecular changes associated with cilia and COVID-19 in chronic rhinosinusitis with nasal polyps. | Sci Rep | 2023 | 37085563 | PubTator, text mining | PubMed |
| Applications of Machine Learning in Chronic Myeloid Leukemia. | Diagnostics (Basel) | 2023 | 37046547 | PubTator, text mining | PubMed |
| KLF4 transcription factor in tumorigenesis. | Cell Death Discov | 2023 | 37031197 | PubTator, text mining | PubMed |
| A Hidradenitis Suppurativa molecular disease signature derived from patient samples by high-throughput RNA sequencing and re-analysis of previously reported transcriptomic data sets. | PLoS One | 2023 | 37023004 | PubTator, text mining | PubMed |
| The immune cell landscape and response of Marek's disease resistant and susceptible chickens infected with Marek's disease virus. | Sci Rep | 2023 | 37005445 | PubTator, text mining | PubMed |
| Single-cell epitope-transcriptomics reveal lung stromal and immune cell response kinetics to nanoparticle-delivered RIG-I and TLR4 agonists. | Biomaterials | 2023 | 37001347 | PubTator, text mining | PubMed |
| Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models. | Immunohorizons | 2023 | 37000496 | PubTator, text mining | PubMed |
| Spatial multiomics map of trophoblast development in early pregnancy. | Nature | 2023 | 36991123 | PubTator, text mining | PubMed |
| Systematic Review on the Metabolic Interest of Glucosinolates and Their Bioactive Derivatives for Human Health. | Nutrients | 2023 | 36986155 | PubTator, text mining | PubMed |
| Transcriptomic Studies on Intracranial Aneurysms. | Genes (Basel) | 2023 | 36980884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51316/papers?page=8